Answers are grounded in this paper and cite their sources.
Demonstrates selective inhibition of EcoRI by β-cyclodextrin sulfate, suggesting its potential as a biochemical probe.
Restriction endonucleases (REs) are sequence-specific DNA-cleaving enzymes that are widely used as tools in molecular biology. Although REs is not typically considered therapeutic targets, their inhibition provides a useful framework for understanding how DNA-binding enzymes can be differentially modulated. In this present study, we investigated the inhibitory activity of β-cyclodextrin sulfate (β-CDsul), a highly anionic macrocycle previously reported to act as a non-selective inhibitor of restriction enzymes. Using NdeI-linearised pBR322 as a defined substrate, we quantified the inhibition of EcoRI, HindIII, and VspI under optimised digestion conditions. β-CDsul inhibited EcoRI with substantially greater potency than HindIII or VspI, exhibiting a 13- to 27-fold difference in IC50 values. In contrast, EDTA inhibited all three enzymes with comparable potency, consistent with non-selective divalent metal ion chelation. Selective inhibition of EcoRI by β-CDsul was maintained in a dual-enzyme system containing both EcoRI and VspI, supporting an enzyme-dependent mode of action. These findings demonstrate that β-cyclodextrin sulfate acts as a selective inhibitor of EcoRI and highlight the potential of polyanionic macrocycles as biochemical probes for differential endonuclease activity.
No takes yet. Share an insight, caveat, or question.
Celikkaya et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: